Reliability and validity of a self-reported measure of medication adherence in patients with type 2 diabetes mellitus in Korea

Journal of International Medical Research

Volumn 41, Issue 4, 2013, Pages 1098-1110

  Lee, Weon Young ^a   Ahn, Jihyun ^a   Kim, Jeung Hee ^b   Hong, Yeon Pyo ^a   Hong, Seung Kwon ^c   Kim, Young Taek ^d   Lee, Seok Hong ^a   Morisky, Donald E ^e  

^a Chung Ang University   (South Korea)

^b Korea University   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Korea Centres for Disease Control and Prevention   (South Korea)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Eight item Morisky Medication Adherence Scale; medication adherence; MMAS 8; psychometrics; self report questionnaire; type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; ETHNIC GROUP; FEMALE; GLYCEMIC CONTROL; GOLD STANDARD; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERVIEW; KOREAN; MAJOR CLINICAL STUDY; MALE; MORISKY MEDICATION ADHERENCE SCALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PREDICTIVE VALUE; PSYCHOMETRY; RATING SCALE; RELIABILITY; SCORING SYSTEM; SELF REPORT; SENSITIVITY AND SPECIFICITY; TEST RETEST RELIABILITY; VALIDITY;

EID: 84887386676     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513484433     Document Type: Article

References (26)

1. Asche C,LaFleur J,Conner C.A review of diabetes treatment adherence and the association with clinical and economic outcomes.Clin Ther. 2011;33:74-109.
2. Cramer JA.A systematic review of adherence with medications for diabetes.Diabetes Care. 2004;27:1218-1224.
3. Bowry AD,Shrank WH,Lee JL,et al.A systematic review of adherence to cardiovascular medications in resource-limited settings.J Gen Intern Med. 2011;26:1479-1491.
4. Korean Ministry of Health and Welfare, Korean Center for Disease Control and Management. The Fourth Korea National Health and Nutrition Examination Survey [KNHANES IV-2] data, http://knhanes.cdc.go.kr/ (2008, accessed 13 May 2013) [in Korean].
5. Bailey CJ,Kodack M.Patient adherence to medication requirements for therapy of type 2 diabetes.Int J Clin Pract. 2011;65:314-322.
6. Garfield S,Clifford S,Eliasson L,et al.Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review.BMC Med Res Methodol. 2011;11:149-149.
7. Morisky DE,DiMatteo MR.Improving the measurement of self-reported medication nonadherence: response to authors.J Clin Epidemiol. 2011;64:262-263.
8. Gonzalez JS,Schneider HE.Methodological issues in the assessment of diabetes treatment adherence.Curr Diab Rep. 2011;11:472-479.
9. Morisky DE,Ang A,Krousel-Wood M,et al.Predictive validity of a medication adherence measure in an outpatient setting.J Clin Hypertens (Greenwich). 2008;10:348-354.
10. Sakthong P,Chabunthom R,Charoenvisuthiwongs R.Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes.Ann Pharmacother. 2009;43:950-957.
11. Al-Qazaz HK,Hassali MA,Shafie AA,et al.The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version.Diabetes Res Clin Pract. 2010;90:216-221.
12. Reynolds K,Viswanathan HN,O'Maley CD,et al.Psychometric properties of the osteoporosis-specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates.Ann Pharmacother. 2012;46:659-670.
13. Korb-Savoldelli V,Gillaizeau F,Pouchot J,et al.Validation of a French version of the 8-item Morisky Medication Adherence Scale in hypertensive adults.J Clin Hypertension. 2012;14:429-434.
14. Wang Y,Kong MC,Ko Y.Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin.Thromb Haemost. 2012;108:789-795.
15. Wild D,Grove A,Martin M,et al.Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation.Value Health. 2005;8:94-104.
16. Costello AB,Osborne JW.Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis.Practical Assessment Res Eval. 2005;10:173-178.
17. Nunnally JC,Bernstein IHPsychometric theory. 3rd ed. New York, NJ: McGraw-Hill, 1994, pp. 248-270.New York, NJ: McGraw-Hill; 1994:248-270.
18. Streiner DL,Norman GRHealth measurement scales: a practical guide to their development and use. 4th ed. Oxford: Oxford University Press, UK, 2008, pp. 167-327.Oxford: Oxford University Press, UK; 2008:167-327.
19. Shrout PE,Fleiss JL.Intraclass correlations: uses in assessing rater reliability.Psychol Bull. 1979;86:420-428.
20. Morisky DE,Green LW,Levine DM.Concurrent and predictive validity of a self-reported measure of medication adherence.Med Care. 1986;24:67-74.
21. Colton TStatistics in medicine. Boston, MA: Little Brown and Company; 1974:189-216.
22. Hu L,Bentler PM.Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives.Struct Equ Model. 1999;6:1-55.
23. Hair JF,Anderson RE,Tatham RL, et alMultivariate data analysis: with readings. 4th ed. Upper Saddle River, NJ: Prentice Hall Inc, 1995, pp. 1-772.Upper Saddle River, NJ: Prentice Hall Inc; 1995:1-772.
24. Cramer JA,Scheyer RD,Mattson RH.Compliance declines between clinic visits.Arch Intern Med. 1990;150:1509-1510.
25. Schechter CB,Walker EA.Improving adherence to diabetes self-management recommendations.Diabetes Spect. 2002;15:170-175.
26. DiMatteo MR,DiNicola DDAchieving patient compliance: the psychology of the medical practitioner's role. New York, NJ: Pergamon Press; 1982:1-335.